-
Analyst: ‘Still chance of a reasonable outcome’ for Walgreens-Rite Aid deal
An Evercore ISI analyst maintained his “buy” rating on Walgreens Boots Alliance stock, stating that although its proposed deadline for a deal with Rite Aid has been delayed, “there is still a chance of a reasonable outcome for both parties.” The companies pushed back the deadline for merger from Jan. 27 to July 31 and trimmed the purchase price paid to Rite Aid to $6.50 to $7 per share — based upon the number of store divestitures the FTC requires — from $9 per share. -
Walmart takes direct aim at Amazon Prime’s free shipping
Walmart just upped the ante in the home shipping war against its rival, Amazon. The chain is ending its ShippingPass program, a fee-based, two-day delivery service, in favor of a free two-day shipping program. Shoppers can now order from more than two million items, and have merchandise shipped to their homes or stores without a membership fee.

